ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET


Saniona AB.
28 announcements.
Time Ticker Company Announcement
07:00 0RQJ Saniona AB
Saniona to Participate in Oppenheimer’s Virtual 2020 Fall Healthcare Life Sciences & MedTech Summit
07:00 0RQJ Saniona AB
Saniona announces that the exercise period of warrants of series TO 2 begins on September 7, 2020
07:00 0RQJ Saniona AB
Change in numbers of shares and votes in Saniona AB (publ)
07:00 0RQJ Saniona AB
Saniona publishes its interim report for the second quarter 2020
07:00 0RQJ Saniona AB
Saniona Expands Executive Team with Appointments of Chief Financial Officer, Chief Communications Officer and Chief Human Resources Officer
07:00 0RQJ Saniona AB
Saniona Announces Poster Presentation at the European Congress of Endocrinology Virtual Annual Meeting
07:00 0RQJ Saniona AB
Saniona invites investors to participate in a conference call and webcast presentation regarding its recent $65 million financing
06:00 0RQJ Saniona AB
Saniona successfully raises USD 65 million (approximately SEK 567 million) in a directed issue of shares
07:00 0RQJ Saniona AB
Saniona Receives Positive Feedback from FDA on Regulatory Path for Tesomet in Prader-Willi Syndrome (PWS)
07:00 0RQJ Saniona AB
Saniona announces that the exercise period of warrants of series TO 1 begins May 11th, 2020
07:00 0RQJ Saniona AB
Saniona appoints Rudolf Baumgartner, M.D., as Chief Medical Officer and Head of Clinical Development
07:00 0RQJ Saniona AB
Saniona Reports Positive Topline Results from Phase 2 Trial of Tesomet in Hypothalamic Obesity
07:50 0RQJ Saniona AB
Saniona publishes Its Annual Report for 2019
07:00 0RQJ Saniona AB
Notice of annual shareholders’ meeting in Saniona AB
07:00 0RQJ Saniona AB
Saniona changes date for Annual General Meeting and updates financial calendar
07:00 0RQJ Saniona AB
Saniona enters into second collaboration agreement with Boehringer Ingelheim in schizophrenia
07:00 0RQJ Saniona AB
Saniona co-founds new migraine therapy company Cephagenix
08:40 0RQJ Saniona AB
Saniona publishes prospectus relating to the rights issue of units
07:00 0RQJ Saniona AB
Saniona publishes its year-end report for 2019
07:00 0RQJ Saniona AB
Change in number of shares and votes in Saniona AB (publ)
07:10 0RQJ Saniona AB
Notice of extraordinary general meeting in Saniona AB
07:00 0RQJ Saniona AB
Saniona completes private placement of SEK 25 million and proposes financing of up to SEK 158 million
07:00 0RQJ Saniona AB
Saniona appoints CNS & rare disease veteran Rami Levin as President and Chief Executive Officer
07:00 0RQJ Saniona AB
Change in number of shares and votes in Saniona AB (publ)
07:00 0RQJ Saniona AB
Saniona AB’s Nomination Committee for the Annual General Meeting 2020
07:00 0RQJ Saniona AB
Saniona publishes its interim report for the third quarter 2019
07:00 0RQJ Saniona AB
Saniona completes patient recruitment in Phase 2a hypothalamic obesity study
07:00 0RQJ Saniona AB
Saniona reports positive Tesomet Phase 2a clinical results in adolescent patients with Prader-Willi syndrome